InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Gregory Philip D, Directeur Scientifique. Director active across 2 companies, notably bluebird bio, Inc.. Aggregated, 21 disclosures have been recorded. Split: 0 buy · 12 sells. Total volume traded: €328k. Activity tracked since 3 May 2021. The latest transaction was filed on 8 January 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations21 total
795 shares@ US$3.75360.8% of flowCommon StockSEC:0001562180-24-000365:0
79,438 shares0Common StockSEC:0001562180-24-000365:1
25,613 shares@ US$3.868527.8% of flowCommon StockSEC:0001562180-24-000304:0
6,159 shares@ US$5.48659.5% of flowCommon StockSEC:0001562180-23-006559:0
3,966 shares@ US$6.12576.8% of flowCommon StockSEC:0001562180-23-006221:0
25,000 shares0Common StockSEC:0001562180-23-000952:0
1,076 shares@ US$10.62813.3% of flowCommon StockSEC:0001562180-23-000485:0
3,794 shares@ US$10.334711.3% of flowCommon StockSEC:0001562180-23-000357:0
2,407 shares@ US$16.232511.7% of flowCommon StockSEC:0001562180-22-005950:0
2,365 shares@ US$13.809910.0% of flowCommon StockSEC:0001562180-22-005710:0
47,500 shares0Common StockSEC:0001562180-22-003846:0
1,452 shares@ US$23.9078100.0% of flowCommon StockSEC:0001562180-22-000410
1,452 shares@ US$23.907850.0% of flowCommon StockSEC:0001562180-22-000410:0
2,092 shares0Common StockSEC:0001628280-21-023653:0
2,092 shares0Common StockSEC:0001628280-21-023653
697 shares0Common StockSEC:0001628280-21-023467:0
697 shares0Common StockSEC:0001628280-21-023467
33,927 shares0Common StockSEC:0001562180-21-005175:0
33,927 shares0Common StockSEC:0001562180-21-005175
39 shares@ US$30.151150.0% of flowCommon StockSEC:0001562180-21-003232
39 shares@ US$30.151150.0% of flowCommon StockSEC:0001562180-21-003232:0
21 of 21 declarations
About Gregory Philip D
Philip D. Gregory is the Chief Scientific Officer at bluebird bio, Inc. and 2seventy bio, Inc. He leads research and development efforts focused on innovation in biotechnology. His scientific expertise is crucial for the development of new therapies and medical solutions.
